<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Sun JT</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Emerging studies have described and analyzed epidemiological, clinical, laboratory, and radiological features of COVID-19 patients. Yet, scarce information is available regarding the association of lipid profile features and disease severity and mortality. &lt;b>Methods:&lt;/b> We conducted a prospective observational cohort study to investigate lipid profile features in patients with COVID-19. From 9 February to 4 April 2020, a total of 99 patients (31 critically ill and 20 severely ill) with confirmed COVID-19 were included in the study. Dynamic alterations in lipid profiles were recorded and tracked. Outcomes were followed up until 4 April 2020. &lt;b>Results:&lt;/b> We found that high-density lipoprotein-cholesterol (HDL-C) and apolipoprotein A-1 (apoA-1) levels were significant</pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pagination>584987</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7746652</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19.</pubmed_title><pmcid>PMC7746652</pmcid><pubmed_authors>Shen L</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Nie P</pubmed_authors><pubmed_authors>Ge H</pubmed_authors><pubmed_authors>Pu J</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Sun JT</pubmed_authors><pubmed_authors>Qu XL</pubmed_authors><pubmed_authors>Ying XY</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Yang F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19.</name><description>&lt;b>Background:&lt;/b> Emerging studies have described and analyzed epidemiological, clinical, laboratory, and radiological features of COVID-19 patients. Yet, scarce information is available regarding the association of lipid profile features and disease severity and mortality. &lt;b>Methods:&lt;/b> We conducted a prospective observational cohort study to investigate lipid profile features in patients with COVID-19. From 9 February to 4 April 2020, a total of 99 patients (31 critically ill and 20 severely ill) with confirmed COVID-19 were included in the study. Dynamic alterations in lipid profiles were recorded and tracked. Outcomes were followed up until 4 April 2020. &lt;b>Results:&lt;/b> We found that high-density lipoprotein-cholesterol (HDL-C) and apolipoprotein A-1 (apoA-1) levels were significant</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-06-01T00:20:31.415Z</modification><creation>2025-06-01T00:20:31.415Z</creation></dates><accession>S-EPMC7746652</accession><cross_references><pubmed>33344516</pubmed><doi>10.3389/fcvm.2020.584987</doi></cross_references></HashMap>